Here, to uncover oncogenic mechanisms in human lung cancer, we carried out a combined transcriptome (NKX2-1 knockdown followed by RNAseq) and cistrome (NKX2-1 binding sites by ChIP-seq) analysis in NKX2-1 amplified NSCLC cell lines. The gene discussed is NKX2-1; the disease is lung carcinoma.